Skip to main content
Erschienen in: BMC Medicine 1/2016

Open Access 01.12.2016 | Research article

Risk factors for hospital re-presentation among older adults following fragility fractures: a systematic review and meta-analysis

verfasst von: Saira A. Mathew, Elise Gane, Kristiann C. Heesch, Steven M. McPhail

Erschienen in: BMC Medicine | Ausgabe 1/2016

Abstract

Background

Older adults hospitalized with fragility fractures are at high risk of negative events that can culminate in re-presentations to hospital emergency departments or readmissions to hospital. This systematic review aimed to identify patient, clinical, or hospital-related factors that are identifiable at the index admission and that may be associated with re-presentations to hospital emergency departments or hospital readmissions in older adults following fragility fractures.

Methods

Four electronic databases (PubMed, CINAHL, Embase, and Scopus) were searched. A suite of search terms identified peer-reviewed English-language articles that examined potential correlates of hospital re-presentation in older adults (mean age ≥ 65 years) who were discharged from hospital following treatment for fragility fractures. A three-stage screening process (titles, abstracts, full text) was conducted by two researchers independently. Participant characteristics, study design, potential correlates examined, analyses, and findings were extracted for studies included in the review. Quality and risk of bias were assessed with the Effective Public Health Practice Project Quality Assessment Tool. The strength of evidence was incorporated into a best evidence synthesis, and meta-analysis was conducted where effect pooling was possible.

Results

Eleven of 35 eligible studies were categorized as high quality studies. These studies reported that age, higher Cumulative Illness Rating scores, American Society of Anesthesiologists scores > 3, longer length of stay, male sex, cardiovascular disease, low post-operative hemoglobin, kidney disease, dementia and cancer were factors identified at the index admission that were predictive of subsequent re-presentation to hospital. Age was the only predictor for which pooling of effects across studies was possible: pooling was conducted for re-presentation ≤ 30 days (pooled OR, 1.27; 95 % CI, 1.14–1.43) and > 30 days (pooled OR, 1.23; 95 % CI, 1.01–1.50).

Conclusions

The best-evidence synthesis, in addition to the meta-analysis, identified a range of factors that may have utility in guiding clinical practice and policy guidelines for targeted interventions to reduce the need for re-presentation to hospital among this frail clinical population. The paucity of studies investigating re-presentations to hospital emergency departments without admission was an important gap in the literature identified in this review. Key limitations were exclusion of non-English language studies and grey literature.

Systematic review registration

PROSPERO CRD42015019379.
Abkürzungen
ASA
American Society of Anesthesiologist
CCI
Charlson comorbidity index
CIRS
cumulative illness rating score
ED
emergency department
HR
hazard ratio
LOS
length of stay
OR
odds ratio

Background

The incidence of fragility fractures is expected to rise as the population of older adults increases [1, 2]. Fragility fractures are fractures sustained from relatively minor forces (e.g., fall from standing height or less) and often occur among people with osteoporosis [3]. Negative outcomes associated with these fractures include disability, morbidity, hospitalization, and increased risk of premature death following the fracture event [4]. These unfavorable outcomes burden patients and increase demand on healthcare services [5, 6].
During an index presentation to hospital after a fragility fracture, the fracture will be examined, and unstable fractures will typically be stabilized using either surgical or non-surgical approaches [7]. Following acute management of the fracture and potentially inpatient rehabilitation, patients are discharged from hospital. However, a re-presentation to hospital may be required soon after discharge [8].
Although there is inconsistency regarding time-frames between studies investigating hospital re-presentations, these may typically be considered to include subsequent unplanned visits to a hospital sometime within the first 2 years following hospitalization [9]. They include emergency department (ED) visits without hospital admission, same-day discharges, and inpatient admissions for 1 or more days. Most older adults returning to hospital within 1 month re-present with a clinical problem or diagnosis related to their index admission, and this is a relatively frequent occurrence among older adults [10].
For those seeking to decrease re-presentation rates after treatment for fragility fractures, it is advantageous to understand the factors that predict re-presentations. To date, no systematic review has examined the range of reported risk factors for hospital re-presentation among older adults following hospitalization for fragility fracture management. One systematic review examined the timing of surgery on negative outcomes following hip fractures [11]. The authors concluded that surgery within 48 hours of hospital admission for a hip fracture reduced the length of hospital stay, mortality rates, and complications. They also concluded that surgical delays increased the risk of complications. Another review examined the outcomes of patients with osteoporotic fractures after hospital discharge [12]. Those patients were reported to be at high risk of morbidity, mortality, and subsequent fracture. Another systematic review summarized the risk factors for hospital readmissions in non-fracture-specific samples and reported that functional disability and comorbidities were correlated with readmission to hospital [13].
Research findings summarized in the aforementioned reviews provide some understanding of the risk of negative outcomes after hospital discharge that may have relevance to people recovering from fragility fractures. However, people recovering from fragility fractures may not have the same risk profile as those who are less frail or admitted to hospital for other health conditions. Therefore, the aim of the present study was to examine potential correlates of hospital re-presentation following fragility fractures in older adults. Specifically, the review focused on reports of patient-, clinical-, or hospital-related factors that could be identified at the time of the initial hospitalization, and re-presentation time-frames of up to 2 years after the initial hospitalization.

Methods

Design

The protocol for this systematic review and meta-analysis has previously been reported and is summarized below [14].

Data sources and searches

Databases were searched for articles in peer-reviewed, English-language journals from the onset of the databases until August 24, 2015. The literature was searched in phases. First, a comprehensive list of terms and synonyms of re-presentations, fracture, elderly, and hospital were combined with Boolean operators to formulate a search string. Second, a systematic search was conducted using the search string to identify relevant studies in four electronic databases: EMBASE, PubMed/Medline, Scopus, and CINAHL via the EBSCO interface. The search strings adapted for each database are presented in Table 1. Finally, the reference lists of included articles were searched for additional relevant studies. Studies identified through reference lists were initially assessed for relevance by study title and abstract. The results were imported into reference management software (Endnote) to manage, extract data and delete duplicate references.
Table 1
Search syntaxes customized for each database
Database
Search syntax
PubMed
(fracture[MeSH Terms]) AND (((readmi* or rehosp* or re-admi* or re-hosp* or re-presentation)) OR “Patient Readmission”[MeSH]) Filters: Aged: 65+ years
CINAHL
“fracture* AND (readmi* or rehosp* or re-admi* or re-hosp* or re-presentation) Age Groups: Aged: 65+ year
Embase
“fracture”/exp and (readmi* or rehosp* or re-admission or re-hospitalisation or re-hospitalization or re-presentation) AND ([aged]/lim OR [very elderly]/lim)
Scopus
ABS fracture* AND (readmi* OR rehosp* OR re-admission OR re-hospitalisation OR re-hospitalization or re-presentation) AND (aged OR elderly OR geriatric OR old*)

Study selection

The selection of articles consisted of three stages of screening (titles, abstracts, full text), which were conducted by SAM and EG independently of each other. A third author (SMM) arbitrated any unresolved disagreements arising during any stage in the search and screening process. Further details about the search and selection strategy were outlined in the protocol [14].
Types of studies
Quantitative studies that explored the correlates of hospital re-presentations in older adults for any time-frame within the first 2 years were eligible for inclusion. Both epidemiological (retrospective and prospective cohort studies) and experimental study designs (that also reported risk factors from analyses of participating cohorts) were eligible for inclusion. Cohort studies were classified as retrospective if the hospital re-presentations had already occurred at the time of study planning and historical cases or events were being audited. In contrast, cohort studies were classified as prospective if study planning occurred prior to the study enrolment period in which hospital re-presentations were observed. Qualitative studies and grey literature were excluded. Authors of included studies were contacted for further information.
Types of participants
Only studies that recruited older adults (mean age ≥ 65 years) who were hospitalized following fragility fractures were included. There were no sex, race, ethnicity, residential status (residential care facilities, or elsewhere in the community), or socioeconomic status restrictions for participants.
Types of outcomes
Studies that examined hospital re-presentation as an outcome were included. Studies that examined correlates of re-presentations in a general patient population but reported separate analyses for re-presentations in older adults with fragility fractures were eligible for inclusion. Outcomes of secondary interest were the number and frequency of re-presentations, the rate of re-presentations, and days since discharge to re-presentation.

Data extraction and quality assessment

Two reviewers conducted the data extraction and quality assessment independently (SAM and EG). A third reviewer (SMM) arbitrated unresolved disagreements. The data extracted included details about the participant characteristics, study design, inclusion and exclusion criteria, risk factors, primary outcomes (re-presentations), and statistical analysis. The quality of individual studies and risk of bias were assessed with the Effective Public Health Practice Project Quality Assessment Tool [15, 16]. This quality assessment tool can be widely used to rate the methodological parameters across all quantitative study designs. A best-evidence synthesis was implemented to integrate the strength of evidence of studies [17].

Data synthesis and analysis

Substantial methodological, statistical, and quality of reporting heterogeneity present in the studies was considered by the investigators to prohibit the valid pooling of effects (meta-analysis) for all potential predictors except age. Age was the only factor for which the definition and method of reporting results were somewhat similar across a pool of studies. Hence, the extracted study characteristics and results from all eligible studies were tabulated and summarized in a best evidence synthesis, and a meta-analysis was performed to obtain pooled estimates for age for re-presentations within 30 days and re-presentations after 30 days using RevMan (version 5.1, Cochrane Collaboration).
For the meta-analysis, odds ratios (ORs) were not able to be directly obtained in a consistent and easily interpretable format (e.g., estimates of effect per increasing year of age) due to differences in statistical analyses and reporting among studies that included age as a potential correlate of hospital re-presentation. To obtain ORs from each study, the following strategy was used. First, effect sizes (ORs, relative risks or hazard ratios) were extracted or calculated from original studies where possible. Because some studies reported effect sizes for age separately for different subgroups, the effect sizes for these groups were merged via inverse variance pooling before entering them into the meta-analysis. If ORs and confidence intervals (CI) were reported, these were taken directly from the studies. If ORs were reported separately for different re-presentation time periods within a study, the results were combined (with meta-clustering) to give one estimate for re-presentation within 30 days, and one estimate for re-presentation after 30 days [18]. If relative risks were reported, prevalence of the risk factors and incidence of hospital re-presentations were used to calculate ORs from available data. Rate ratios and standardized mean differences were extracted and calculated from P values to calculate ORs, where relevant. The random effects model of analysis was used to best account for heterogeneity, and tests of heterogeneity (I2) were performed. A sensitivity analysis was performed to examine the effect of removing one small study [19] with an age effect estimate for re-presentation within 30 days that fell outside the confidence ranges of any other included studies (OR estimate was considerably higher).

Results

The outcome of the study identification and selection process is outlined in Fig. 1. In summary, after the removal of 339 duplicates, a total of 430 unique studies were identified across four databases. Eighty-eight articles were deemed eligible for full text screening, of which 53 studies were excluded for not meeting the inclusion criteria. The remaining 35 studies were included in this review.

Study characteristics

The characteristics of the included studies are described in Table 2. The review included one randomized controlled trial that reported the effect of cholecalciferol and physiotherapy on hospital readmissions, but also reported correlates of re-presentation [20]. The remaining 34 studies were retrospective cohort studies (n = 23), prospective cohort studies (n = 9), an interrupted time series study (n = 1) [21], or a combination of retrospective and prospective cohort designs (n = 1) [22]. Despite the delineation between retrospective and prospective cohort studies in this review, it is perhaps noteworthy that both types typically used information sources recorded at (or at least near) the time of the events of interest (e.g., in patient medical records). Subsequently, the authors of this review did not consider there to be a substantial difference in interpretation of the reliability of data originating from the included retrospective and prospective studies. All studies addressed risk factors for hospital readmissions; none addressed risk factors for hospital re-presentations more broadly, which could have included ED presentations without admission to hospital. Therefore, below, only factors associated with readmissions are presented.
Table 2
Characteristics of studies included in the systematic review
Author and year of publication
Country
Site
Study design
Sample characteristics
Sample size/population
Study time period
Fracture site
Basques et al. (2015) [30]
USA
370 hospitals
Retrospective cohort
>70 years
8434
2011–2012
Hip
Bischoff-Ferrari et al. (2010) [20]
Switzerland
Single hospital
Randomized controlled trial
≥65 years
173
2005–2007
Hip
Boddaert et al. (2014) [21]
France
Single hospital
Interrupted time series
≥70 years
334
2005–2012
Hip
Fox et al. (1998) [31]
USA
8 hospitals
Prospective cohort
≥65 years
306
1990–1991
Hip
French et al. (2008) [25]
USA
Veterans Health Administration Medical Centre
Retrospective cohort
≥65 years
41,331
1999–2003
Hip
Giusti et al. (2008) [32]
Italy
Single hospital
Prospective cohort
≥70 years
236
2000–2001
Hip
Golinvaux et al. (2014) [48]
USA
350 hospitals
Retrospective cohort
≥65 years
9938
2005–2012
Hip
Gregersen et al. (2011) [42]
Denmark
Single hospital
Prospective cohort
≥65 years (Nursing Home Residents)
233
2006–2010.
Hip
Hageman et al. (2014) [43]
USA
Level 1 trauma center
Retrospective cohort
Mean age > 65
890
2008–2011
Hip
Halm et al. (2003) [27]
USA
4 hospitals
Prospective cohort
Mean age > 65
559
1997–1998
Hip
Halm et al. (2003) [33]
USA
4 hospitals
Prospective cohort
Mean age > 65
551
1997–1998
Hip
Halm et al. (2004) [34]
USA
4 hospitals
Prospective cohort
Mean age > 65
550
1997–1998
Hip
Härstedt et al. (2015) [35]
Sweden
Single hospital
Prospective cohort
Mean age > 65
272
2009–2011
Hip
Heidari et al. (2012) [26]
UK
62 hospital pharmacies
Retrospective cohort
Mean age > 65
255,841
2003–2007
Hip
Heyes et al. (2015) [29]
Ireland
Single hospital
Prospective cohort
Mean age > 65
451
2010–2012
Hip
Hsaio et al. (2011) [23]
Taiwan
Health insurance database
Retrospective cohort
Mean age > 65 (women)
11,278
2001–2007
Hip/Vertebra
Intrator and. Berg (1998) [44]
USA
Medicare beneficiaries
Retrospective cohort
≥70 years
324
1987–1991
Hip
Jou et al. (2014) [24]
Taiwan
Health insurance database
Retrospective cohort
Mean age > 65 (women)
9467
2003–2006
Hip
Kates et al. (2014) [28]
USA
Level 3 trauma center
Retrospective cohort
≥65 years
1081
2005–2010
Hip
Kates et al. (2015) [49]
USA
Level 3 trauma center
Retrospective cohort
≥65 years
1081
2005–2010
Hip
Khan et al. (2012) [36]
UK
Single hospital
Retrospective cohort
Mean age > 65
467
2009–2010
Hip
Kiel et al. (1994) [45]
USA
43 nursing homes
Prospective cohort
Mean age > 65
2624
1984–1988
Hip
Le-Wendling et al. (2012) [37]
USA
Single hospital
Retrospective cohort
≥65 years
308
2006–2008
Hip
Ling et al. (2013) [19]
Singapore
Single hospital
Retrospective cohort
Mean age > 65
254
2009–2010
Hip
Merchant et al. (2005) [38]
Singapore
Single hospital
Retrospective cohort
Mean age > 65
180
2001–2001
Hip
Ottenbacher et al. (2003) [46]
USA
171 hospitals
Retrospective cohort
Mean age > 65
9956
1994–1998
Hip
Pollock et al. (2015) [50]
USA
Level 1 trauma center
Retrospective cohort
Mean age > 65
1482
2005–2012
Hip
Radcliff et al. (2008) [51]
USA
Veterans Health Administration Medical Center
Retrospective cohort
Mean age > 65
5683
1998–2003
Hip
Riggs et al. (2010) [39]
USA
Single hospital
Retrospective cohort
≥65 years
606
2004–2006
Hip
Teixeira et al. (2009) [40]
France
Single hospital
Retrospective cohort
≥70 years
5709
2005–2006
Hip
Toson et al. (2015) [53]
Australia
247 hospitals
Retrospective cohort
Mean age > 65
47,698
2001–2010
Hip
Toy et al.(2014) [41]
USA
370 hospitals
Retrospective cohort
≥65 years
850
2011–2012
Vertebra
Tsai et al. (2013) [47]
Taiwan
National Health Insurance
Retrospective cohort
≥70 years
9238
2004–2007
Vertebra
Vochteloo et al. (2011) [22]
Netherlands
450 hospitals
Retrospective and prospective cohort
≥65 years
1222
2005–2010
Hip
Zhang et al. (2014) [52]
USA
State Inpatient Database
Retrospective cohort
Mean age > 65
27,017
2005–2010
Proximal humerus
Approximately half of the studies (n = 19, 54 %) were from the United States, with the remainder conducted in France (n = 2), Singapore (n = 2), Taiwan (n = 2), or elsewhere (n = 9). Sixteen studies (46 %) specifically targeted patients aged ≥ 65 years, although all reported a mean age > 65 years. Two studies included women only [23, 24]. One study restricted the analyses to nursing home residents [25].
The sample size of studies ranged from 173 patients [20] to 255,841 patients [26]. There were two kin studies that investigated different risk factors from the same large dataset [27, 28]. The total length of the enrollment period for the studies ranged from ≤ 2 years for 15 studies [27, 2941], 3–5 years for eight studies [20, 22, 2426, 4247], 6–8 years for eight studies [21, 23, 28, 30, 4852], and up to 10 years for one study [53]. This review focused on findings reported for re-presentations within the first 2 years after the index hospital event. Specifically, the observed timeframe for hospital re-presentations for findings reported in this review extended from 7 days to 18 months after the index hospital event [24, 31]. Hip fracture was the most common fracture site (n = 32 studies) [2040, 4246, 4851, 53]. Two studies examined patients with vertebral fractures, and one study examined patients with proximal humerus fractures [41, 47, 52].

Risk factors associated with re-presentations

The risk factors for hospital re-presentations that were examined are listed in Table 3 by shortest to longest observation time-frame after the index event in which re-presentation may have occurred. Most studies examined correlates of readmission within 30 days of the index event (i.e., 30 days since the initial hospital discharge (n = 8), an operation (n = 6), or admission to a nursing home (n = 1)). Other studies examined correlates within 60 days (n = 3), 90 days (n = 3), 6 months (n = 2), and 1 year (n = 7) from the index event. Two studies used multiple follow-up periods [24, 47]. For the purpose of this synthesis, correlates were categorized into patient characteristics and other clinical or hospital indicators.
Table 3
Reported associations between patient or clinical characteristics with risk of hospital re-presentations
Study
Patient characteristics
Association
Clinical/service characteristics
Association
Percentage of re-presentations
Readmission a within 30 days
Readmission within 7 days from discharge
Tsai (2013) [47]
Hospitalization for all reasons
OR = 0.48 (0.32–0.72)
Not investigated
 
Hospitalization for all reasons: 3.44 %
Fracture related diagnoses
OR = 0.28 (0.12–0.68)
Fracture related diagnoses: 0.69 %
Musculoskeletal disorder
OR = 0.08 (0.01–0.88)
Musculoskeletal disorders: 0.20 %
Hospitalization for other diagnoses
OR = 0.67 (0.41–1.09)
Hospitalization for other diagnoses: 2.55 %
Readmission within 14 days from discharge
Jou et al. (2014) [24]
14 days:
 
14 days: Medical center
Referent
50–74 y (3.21 %)
Age < 75 Age ≥ 75
Referent
Regional hospital
District hospital
HR = 1.56 (1.08–2.25)
HR = 1.36 (1.08–1.71)
HR = 4.47 (3.20–6.26)
14 days:
CCI score 0
CCI score ≥ 2
 
LOS
≤10 days
≥11 days
 
≥75 y (4.16 %)
Referent
Referent
HR = 1.52 (1.22–1.92)
HR = 0.25 (0.19–0.34)
14 days: Geographic regions
 
Northern
Central
Southern
Eastern
Referent
HR = 1.21 (0.89–1.64)
HR = 1.17 (0.89–1.54)
HR = 0.96 (0.47–1.96)
Readmission within 28 days from discharge
Khan et al. (2012) [36]
Age
OR = 1.06 (1.02–1.10)
Not investigated
 
11 %
Diabetes
OR = 3.34 (1.54–7.25)
History of neurological disorders
OR = 5.66 (2.79–11.47)
Admission other than home
OR = 2.36 (1.19–4.66)
Readmission within 30 days from discharge
Boddaert et al. (2014) [21]
CIRS score
RR = 1.08 (1.00–1.16)
Intervention vs. control group
RR = 0.40 (0.23–0.70)
Orthopedic group (usual care) = 17 %
Age
RR = 0.99 (0.95–1.03)
  
Geriatric group (intervention) = 5 %
Male sex
RR = 0.76 (0.41–1.41)
French et al. (2008) [25]
Chronic heart failure
OR = 1.24 (1.16–1.33)
Inpatient LOS
OR = 1.01 (1.01–1.02)
18 %
Cardiac arrhythmias
OR = 1.11 (1.04–1.17)
30 % occurred in the first week
Other neurological disorder
OR = 1.15 (1.05–1.26)
60 % within 2 weeks
Chronic pulmonary disease
OR = 1.33 (1.25–1.40)
81 % within 3 weeks
Diabetes mellitus without chronic
complication
 
OR = 1.32 (1.15–1.52)
Renal failure
OR = 1.43 (1.29–1.60)
Coagulopathy
OR = 1.33 (1.16–1.52)
Weight loss
OR = 1.24 (1.07–1.44)
Fluid and electrolyte disorders
OR = 1.11 (1.04–1.20)
Deficiency anemia
OR = 1.16 (1.09–1.25)
Alcohol abuse
OR = 0.86 (0.75–0.98)
Psychosis
OR = 1.16 (1.00–1.34)
Depression
OR = 1.06 (0.95–1.18)
Heidari et al. (2012) [26]
Not investigated
 
Hospital drug policy for chemical thromboprophylaxis
 
55 %
Aspirin
OR = 1.03 (0.87–1.23)
Heparin drug policy
OR = 1.06 (0.97–1.16)
Low-dose heparin
OR = 1.09 (0.93–1.28)
Jou et al. (2014) [24]
30 days:
 
30 days: Medical center
Referent
50–74 y (3.21 %) ≥75 y (4.87 %)
Age < 75 Age ≥ 75
Referent
Regional hospital
District hospital
HR = 1.51 (1.10-2.09)
HR = 1.34 (1.07–1.62)
HR = 3.82 (2.83–5.14)
30 days:
 
LOS
 
CCI score 0
CCI score ≥ 2
Referent
≤10 days
≥11 days
Referent
HR = 1.60 (1.30–1.97)
HR = 0.32 (0.25–0.41)
30 days: Geographical regions
 
Northern
Central
Southern
Eastern
Referent
HR = 1.25 (0.94–1.67)
HR = 1.20 (0.93–1.54)
HR = 1.00 (0.52–1.92)
Kates et al. (2014) [28]
Age > 85
OR = 1.52 (1.02–2.26)
Time to surgery > 24 h
OR = 1.50 (1.00–2.25)
11 %
CCI ≥ 4
OR = 1.70 (1.02–2.81)
Delirium
OR = 1.65 (1.13–2.40)
Dementia
OR = 1.61 (1.12–2.33)
History of arrhythmia with pacemaker
OR = 1.75 (1.11–2.76)
Placement presence of a pre-op arrhythmia
OR = 1.62 (1.09–2.39)
Partial or complete disability with ADL
OR = 1.54 (1.05–2.26)
Kates et al. (2015) [49]
Age > 85
OR = 1.58 (1.02–2.26)
Not investigated
 
11.9 %
Male
OR = 1.49 (1.00–2.24)
Assisted living
OR = 1.52 (0.82–2.59)
Skilled nursing
OR = 1.24 (0.84–1.85)
Parker mobility medium (5–8)
OR = 1.81 (0.98–3.35)
Parker mobility low (0–4)
OR = 1.50 (0.85–2.64)
Charlson score medium (2–3)
OR = 1.51 (1.03–2.25)
Charlson score high (4 or more)
OR = 1.65 (1.00–2.74)
Partial or complete disability
OR = 1.51 (1.03–2.25)
Delirium
OR = 1.66 (1.14–2.41)
Preoperative arrhythmia
OR = 1.62 (1.09–2.39)
Hematoma
OR = 7.51 (0.47–1.21)
Urinary tract infection
OR = 1.84 (0.39–8.84)
Pacemaker
OR = 1.75 (1.11–2.76)
Diabetes
OR = 1.91 (1.22–2.99)
Dementia
OR = 1.61 (1.12–2.22)
GERD
OR = 1.44 (0.99–2.10)
Cardiac disease
OR = 1.02 (0.66–1.59)
Alcoholism
OR = 1.12 (0.46–2.68)
Tobacco use
OR = 0.99 (0.56–1.73)
Le-Wendling et al. (2012) [37]
Not investigated
 
Local vs. general anesthetic
OR = 2.0 (1.0-4.0)
19 %
Pollock et al. (2015) [50]
Pre-existing pulmonary disease
OR = 1.88 (1.30–2.72)
Discharge to skilled nursing facility
OR = 1.5 (1.04–2.14)
9 %
Hospital LOS > 8 days
OR = 1.88 (1.30–2.72)
Toson et al. (2015) [53]
Myocardial infarction
OR = 1.1 (1.0–1.2)
Not investigated
 
16 %
Congestive heart failure
OR = 1.2 (1.1–1.3)
Peripheral vascular disease
OR = 1.2 (1.0–1.3)
Cerebrovascular accident
OR = 1.1 (1.0–1.2)
Dementia
OR = 0.8 (0.8–0.9)
Chronic pulmonary disease
OR = 1.1 (1.0–1.2)
Connective tissue disorder
OR = 1.2 (1.0–1.4)
Peptic ulcer
OR = 1.2 (1.0–1.5)
Mild liver disease
OR = 1.3 (1.0–1.7)
Diabetes without chronic
complications
 
OR = 1.1 (1.0–1.2)
Diabetes with chronic complications
OR = 1.2 (1.1–1.3)
Hemiplegic or paraplegia
OR = 0.9 (0.8–1.1)
Renal disease
OR = 1.3 (1.2–1.5)
Any malignancy
OR = 1.4 (1.2–1.6)
Metastatic solid tumor
OR = 1.1 (0.9–1.4)
Moderate or severe liver disease
OR = 5.0 (3.3–7.5)
Readmission within 30 days post-operative
Basques et al. (2015) [30]
Age ≥ 90
OR = 1.35 (1.09–1.67)
Discharge to a facility
OR = 1.42 (1.08–1.86)
10 %
Male
OR = 1.40 (1.20–1.63)
ASA class 3
OR = 1.40 (1.09–1.69)
BMI ≥ 35
OR = 1.73 (1.24–2.44)
ASA class 4
OR = 1.90 (1.44–2.51)
History of pulmonary disease
OR = 1.46 (1.22–1.75)
  
Hypertension
OR = 1.21 (1.02–1.45)
Steroid use
OR = 1.38 (1.04–1.83)
Partially dependent functional status
OR = 1.31 (1.11–1.54)
Fully dependent functional status
OR = 1.41 (1.01–1.97)
Golinvaux (2014) [48]
Non-insulin dependent diabetes mellitus
 
Not investigated
 
Without diabetes = 5 %, Non-insulin dependent diabetes mellitus = 7 %,
 
RR = 1.4 (1.0–2.0)
  
Insulin dependent diabetes mellitus = 7 %
Insulin-dependent diabetes mellitus
RR = 1.4 (0.9–2.2)
Hageman et al. (2014) [43]
CCI and age
OR = 1.1, P < 0.01, R2 = 0.03
Not investigated
 
2 % readmitted without surgical adverse event
4 % readmitted with surgical adverse event
Ling et al. (2013) [19]
Age 60–70
Referent
Not investigated
 
9 %
Age 70–80
OR = 1.60 (0.31–8.22)
Age 80–90
OR = 3.91 (0.83–18.4)
Age > 90
OR = 7.21 (1.28–40.65)
Female
Referent
Male
OR = 0.75 (0.27–2.10)
Intertrochanteric
OR = 0.84 (0.36–1.95)
Comorbidity = 0
Referent
Comorbidity > 1
OR = 0.73 (0.26–2.04)
Comorbidity > 2
OR = 0.48 (0.10–2.26)
Comorbidity > 3
OR = 1.53 (0.45–5.19)
Renal failure
OR = 2.49 (0.50–12.4)
Serum albumin
OR = 2.09 (0.69–6.36)
Serum iPTH
OR = 1.01 (0.42–2.47)
Vitamin D deficiency
OR = 1.00 (0.43–2.33)
Euthyroid
Referent
Overt hypothyroidism
OR = 1.75 (0.35–8.89)
Thyroid dysfunction
OR = 1.19 (0.47–3.03)
Subclinical hypothyroidism
OR = 0.44 (0.05–3.54)
Radcliff (2008) [51]
White race
OR = 1.32
Plate/screw (CPT 27244)
OR = 1.26
7 %
Age 65–74
Referent
Open reduction (CPT 27236)
OR = 1.13
Age 75–84
OR = 1.17
Hemiarthroplasty (CPT 27125)
OR = 1.30
Age ≥ 85
OR = 0.95
Percutaneous fixation (CPT 27235)
OR = 1.05
Currently smoking
OR = 0.94
Intramedullary implant (CPT 27245)
OR = 0.92
Alcohol use (>2 drinks/day)
OR = 1.29
General anesthesia
OR = 0.97
Partial independence
OR = 1.04
Blood transfusion (1 U)
OR = 1.01
Total independence
OR = 0.70
Surgery 4 days after admission
OR = 0.70
Impaired sensorium
OR = 1.67
Weekend surgery
OR = 1.15
Renal insufficiency
OR = 1.46
Wound not “clean”
OR = 1.44
Steroid use
OR = 1.10
Emergency admission
OR = 0.74
Disseminated cancer
OR = 0.87
ASA class 3
OR = 1.38
Congestive heart failure
OR = 1.28
ASA class 4 or 5
OR = 1.60
Dementia
OR = 0.75
Diabetes
OR = 1.09
Hemiplegia
OR = 1.02
Severe chronic obstructive pulmonary disease
OR = 1.24
Recent weight loss
OR = 0.99
Hyponatremia
OR = 1.73
Toy et al. (2014) [41]
History of pulmonary disease
OR = 2.0
Inpatient status before procedure
OR = 1.9
10.8 %
Tsai (2013) [47]
Hospitalization for all reasons
OR = 0.74 (0.59–0.93)
Not investigated
 
Hospitalization for all reasons: 14.73 %
Fracture related diagnoses
OR = 0.69 (0.45–1.05)
Fracture-related diagnoses: 3.73 %
Musculoskeletal disorders
OR = 0.60 (0.37–0.98)
Musculoskeletal disorders: 2.36 %
Hospitalization for other diagnoses
OR = 0.83 (0.62–1.12)
Hospitalization for other diagnoses: 9.23 %
Readmission to hospital within 30 days of admission to nursing home
Kiel et al. (1994) [45]
Age 74–85
OR = 0.58 (0.40–0.83)
Not investigated
 
12.4 %
Age > 85
OR = 0.55 (0.38–0.80)
Secondary neurological diagnoses
OR = 0.75 (0.56–1.00)
Living with someone
OR = 1.44 (1.12–1.87)
Any dependency in ADLs
OR = 1.45 (1.08–1.93)
Ability to walk
OR = 1.54 (1.16–2.05)
Readmission >30 days
Readmission to hospital within 60 days from discharge
Halm et al. (2003) [27]
Active clinical issue in the 24 h before discharge
OR = 1.6 (1.0–2.6)
Not investigated
 
18.8 %
New impairment in the 24 h before discharge
OR = 1.7 (1.2–2.3)
Halm et al. (2003) [33]
Transfusion when Hb < 10.0 g/dL
OR = 0.52 (0.28–0.97)
  
16.9 %
Halm et al. (2004) [34]
Hb on admission
OR = 0.69 (0.49–0.95)
Not investigated
 
16.9 %
Hb lowest preoperative
OR = 0.65 (0.48–0.89)
Hb lowest postoperative
OR = 0.78 (0.64–0.95)
Readmission within 80 and 180 days
Ottenbacher et al. (2003) [46]
Age
Beta = 0.943, SEM = 0.374, LR = 3.51
Not investigated
 
16.7 %
Ethnicity × gender
Beta = 0.012, SEM = 0.005, LR = 2.54
FIM rating
Beta = −0.825, SEM = 0.293, LR = 4.86
Readmission within 90 days from discharge
Vochteloo et al. (2011) [22]
Age
OR = 0.97 (0.94-0.99)
ASA
OR = 1.43 (0.99–2.09)
Anemic group 12.9 %, Non-anemic group 9.0 %
Anemia
RR = 1.24 (1.04–1.49)
General anesthesia
OR = 0.35 (0.13–0.99)
Readmission 90 days from surgery
Zhang et al. (2014) [52]
Male
HR = 0.77 (0.72–0.83)
Hemiarthroplasty
HR = 0.77 (0.71–0.83)
90 day readmission rate = 14 %
African-American race
HR = 1.22 (1.02–1.46)
RTSA
HR = 0.82 (0.67–0.99)
15 % for open reduction-internal fixation and RTSA
Medical comorbidities (per diagnosis)
HR = 1.20 (1.18–1.22)
 
13 % for hemiarthroplasty
Insurance with Medicaid
HR = 1.27 (1.08–1.49)
Private insurance
HR = 0.82 (0.74–0.91)
Discharge status – home with services
HR = 1.19 (1.07–1.32)
Transfer to facility nursing or rehab
HR = 1.99 (0.82–2.18)
Gregersen et al. (2011) [42]
Postop Hb levels ≤ 6 mmol/L
OR = 3.24 (1.15–9.14)
Intervention care
OR = 0.47 (0.23–0.94)
14 % intervention care
Age
OR = 2.98 (1.08–8.21)
26 % standard care
Readmission within 180 days from surgery
Tsai (2013) [47]
Hospitalization for all reasons
OR = 0.93 (0.78–1.38)
Not investigated
 
Hospitalization for all reasons: 38.31 %
Fracture related diagnoses
OR = 0.90 (0.67–1.21)
Fracture related diagnoses: 9.14 %
Musculoskeletal disorders
OR = 1.03 (0.77–1.38)
Musculoskeletal disorders: 9.43 %
Hospitalization for other diagnoses
OR = 0.93 (0.77–1.13)
Hospitalization for other diagnoses: 26.72 %
Readmissions within 6 months from discharge
Härstedt et al. (2015) [35]
Hypertension
OR = 2.0 (1.2–1.9)
Not investigated
 
32 %
Atrial Fibrillation
OR = 0.80 (0.40–1.61)
  
73 % were admitted once only
Myocardial infarction
OR = 0.70 (0.30–1.64)
Angina pectoris
OR = 0.49 (0.19–1.26)
Heart failure
OR = 0.69 (0.29–1.61)
Pacemaker
OR = 6.64 (1.68–26.33)
Valvular heart disease
OR = 0.87 (0.17–4.60)
Syncope
OR = 0.99 (0.36–2.71)
Stroke
OR = 0.66 (0.31–1.40)
Pulmonary embolism/deep vein thrombosis
OR = 2.72 (0.80–9.24)
Peripheral vascular disease
OR = 1.01 (0.33–3.08)
Parkinson’s disease
OR = 1.32 (0.32–5.70)
Epilepsy
OR = 0.26 (0.03–2.15)
Cognitive disorder (dementia)
OR = 1.68 (0.94–3.01)
Depression
OR = 1.54 (0.63–3.78)
Diabetes mellitus
OR = 0.64 (0.29–1.42)
Thyroid disease
OR = 1.47 (0.70–3.12)
Respiratory disease (COPD)
OR = 0.98 (0.42–2.26)
Malignancy
OR = 1.16 (0.57–2.37)
Autoimmune disorders
OR = 2.30 (0.87–6.10)
Prostate tumor (men)
OR = 4.99 (0.92–27.18)
Previous fracture
OR = 1.70 (0.86–3.36)
Osteoporosis
OR = 0.30 (0.07–1.40)
Diseases in the kidney and urinary
tract
 
OR = 1.72 (0.57–5.16)
Anemia
OR = 1.19 (0.43–3.32)
ASA classification per one grade
OR = 1.67 (0.99–2.80)
Riggs et al. (2010) [39]
Discharge to rehabilitation
Standard coeff −0.095 (−0.102 to −0.11)
LOS 75th quartile ≥ 9 days)
Standard coefficient 0.151 (0.044–0.141)
8.3 %
Any days in Intensive Care Unit
Standard coefficient 0.168 (0.097–0.271)
Readmission after 12 months from discharge
Bischoff- Ferrari (2010) [20]
  
2000- vs. 800-IU/d dosage of cholecalciferol
Relative rate different, −39 % (−62 % to −1 %)
70 % had 1 readmission, 22 % had 2 readmissions and 7 % had 3 readmissions
Efficacy analysis: 2000 IU/d dose
Relative rate different, −55 % (−79 % to −2 %)
Giusti et al. (2008) [32]
Age 76–85
OR = 0.77 (0.29–2.01)
Not investigated
 
30.1 %
Age > 85
OR = 0.46 (0.16–1.29)
CIRS-SI 1.5–1.9
OR = 5.95 (1.66–21.3)
CIRS-SI > 1.9
OR = 7.05 (1.68–29.7)
2 month ADL Katz Index 0–2
OR = 3.02 (1.09–8.32)
Heyes et al. (2015) [29]
Female
OR = 1.34 (0.65–2.76)
Time to surgery 36 h to 6 days
OR = 1.62 (0.156–2.44)
44 %
Cephalomedullary nail
OR = 1.51 (0.40–1.08)
>6 days
OR = 1.29 (0.198–3.02)
Hip hemiarthroplasty/THR
OR = 3.10 (0.19–1.80)
Inpatient stay > 7 days
OR = 3.13 (0.12 –0.62)
Moderate alcoholic
OR = 1.36 (0.31–1.73)
Inpatient stay of 7–14 days
OR = 7.04 (0.05 –0.34)
Alcoholic
OR = 1.52 (0.26–1.66)
Inpatient stay of 14–21 days
OR = 2.90 (0.18 –0.64)
Affected side-right
OR = 1.10 (0.57–1.45)
Inpatient stay of 21–28 days
OR = 1.83 (0.25–0.16)
Ex-smoker
OR = 1.14 (0.64–2.00)
Inpatient stay of 28–35 days
OR = 2.11 (0.19–1.17)
Smoker
OR = 1.24 (0.56–2.72)
ASA score > 2
OR = 3.68 (0.06–1.15)
Residential care/nursing home residence
OR = 1.71 (1.34–1.98)
ASA score > 3
OR = 1.95 (0.17–1.48)
ASA score > 4
OR = 2.14 (0.16–1.33)
Hb > 2 g/dL drop
OR = 1.29 (0.48–1.24)
Transfusion status < 2 units
OR = 1.12 (0.31–4.00)
Admission glucose > 7.8 mmol/L
OR = 1.18 (0.66–2.09)
Transfusion status > 2 units
OR = 1.85 (0.48–7.04)
Discharge glucose > 7.8 mmol/L
OR = 1.05 (0.53–1.70)
Total protein
OR = 1.13 (0.53–1.46)
Admission eGFR < 45
OR = 1.04 (0.50–1.83)
Discharge eGFR < 45
OR = 1.04 (0.47–1.96)
Hsaio et al. (2011) [23]
Long-term use of alendronate reduces risk
HR = 0.27 (0.15–0.78)
Not investigated
 
8.6 % cases untreated cohort; 6.3 % alendronate users; 7.6 % other anti organophosphorous drug users
Intrator et al. (1998) [44]
Home healthcare usage
OR = 0.77 (0.52–1.15)
Not investigated
 
Rehab only group 34.1 % Rehab and home health group 27.2 %
Jou et al. (2014) [24]
1 year:
 
1 year: District hospital
HR = 2.24 (1.82–2.75)
50–74 y (6.02 %)
Age < 75
Age ≥ 75
Referent
LOS
 
≥75 y (8.38 %)
HR = 1.46 (1.24–1.73)
≤10 days
≥11 days
Referent
1 year: CCI = 0
CCI score ≥ 2
Referent
HR = 0.51 (0.43–0.60)
HR = 1.28 (1.09–1.51)
1 year: Geographic regions
 
Northern
Central
Southern
Eastern
Referent
HR = 1.12 (0.90–1.39)
HR = 1.07 (0.88–1.29)
HR = 0.89 (0.54–1.46)
Merchant (2005) [38]
Post-operative complications
After adjustment for potential covariates the presence of postoperative complications was not significant (P > 0.05, coefficients not presented)
Not investigated
 
31.7 %
Teixeira et al. (2009) [40]
Male (predicts related first readmission)
HR = 1.25 (1.08–1.46)
Teaching hospital vs. public hospital (predicts related first readmission)
 
32 %
Male
HR = 1.36 (1.16–1.59)
HR = 0.86 (0.79–0.95)
Increasing age (predicts unrelated first readmission)
HR = 0.94 (0.89–0.99)
Index stay in a private hospital
HR = 0.78 (0.67–0.9)
Cancer
HR = 1.41 (1.03–1.94)
Teaching hospital (predicts unrelated first readmission)
HR = 0.87 (0.79–0.95)
Kidney disease
HR = 1.38 (1.00–1.90)
Dementia (predicts related first readmission)
HR = 1.21 (1.01–1.46)
Dementia (predicts unrelated first readmission)
HR = 0.68 (0.53–0.87)
Readmission within 18 months from discharge
Fox et al. (1998) [31]
Performance on balance tests at 2 months post fracture
Beta = −0.155, P= 0.01
   
Gait score
Beta = −0.013, P = 0.83
Mobility score
Beta = −0.098, P = 0.11
CCI, Charlson comorbidity index; CIRS, Cumulative illness rating scale – severity index; ASA, American Society of Anesthesiologists score; LOS, length of stay; ADL, activities of daily living; FIM, functional independence measure; CM, conservative treatment; RTSA, reverse total shoulder arthroplasty; Hb, hemoglobin; HR, hazards ratio; OR, odds ratio; LR, likelihood ratio; RR, relative risk
aThe term readmission is being used as the studies have reported on hospital readmissions rather than hospital re-presentations
Bold text indicates a significant association (p <0.05)

Patient characteristics

Patient characteristics that were investigated as possible risk factors were age, gender, physical function, and level of independence with daily living. Seven of the 14 studies that investigated age reported a significant positive association [19, 21, 24, 28, 30, 36, 49]. Six studies examined the effect of male sex on subsequent hospital readmission, and three found male sex to be a risk factor of readmission [25, 30, 40]. Two studies reported being aged > 75 years and receiving treatment from a regional hospital for the index hospital event as predictors of hospital readmissions at 14 days, 30 days, and 1 year after the index event [24, 47]. A study that examined predictors of hospital readmissions within 1 year of discharge identified male gender and increasing age as risk factors of hospital readmissions [40]. Four out of five studies that examined the Cumulative Illness Rating Score (CIRS) identified that a CIRS score > 2 was predictive of hospital readmission [21, 24, 28, 32]. Five studies that investigated residential status of patients after the index hospital event found a positive correlation between discharge to a nursing home and 30-day risk of hospital readmission [29, 30, 36, 45, 50].
Physical and mental health comorbidities were also examined as potential risk factors for readmissions; there was, however, a considerable variation in the comorbidities investigated. Eight studies examined the association between cardiovascular disease and hospital readmission: five of the studies found a positive association [25, 28, 30, 49, 50]. Eight studies examined the association between diabetes and readmission. Three of these studies reported a significant positive association [25, 36, 49], but two that only included surgical cases did not find an association. Two of the five studies that investigated renal insufficiencies and kidney diseases as predictors of readmission reported significant positive associations [25, 51]. One of the three studies that examined post-surgical anemia and one of the four studies that specifically examined hemoglobin (Hb) reported a significant positive association (Hb < 6 mmol/L) with hospital readmission within 90 days [42]. One study identified cancer and dementia as comorbidities at the index event to be predictive of hospital readmission within a year [40]. One study examined body mass index (BMI) and reported that patients with a BMI > 35 were at an elevated risk of being readmitted to hospital after discharge [30]. Among the cognitive disorders, dementia was the most common comorbidity examined and was positively associated with readmissions in three of the six studies in which it was investigated [28, 40, 49].
In total, comorbidities were significant risk factors and reasons for hospital readmission in 20 studies. The most common comorbidities identified were myocardial infarction (n = 9) [25, 28, 35, 36, 40, 41, 48, 51, 53], pulmonary embolism (n = 7) [25, 28, 3941, 51, 53], urinary tract infection (n = 6) [36, 38, 41, 48, 50, 51], pneumonia (n = 9) [20, 29, 36, 38, 41, 42, 48, 50, 51], sepsis (n = 5) [20, 36, 41, 48, 51], and renal failure (n = 4) [36, 41, 48, 53]. Other frequent reasons for readmission included surgical complications (n = 6) [28, 40, 41, 43, 50, 52], re-fractures (n = 5) [24, 28, 42, 50], and falls (n = 3) [35, 36, 38].

Other clinical and hospital indicators

A range of other clinical and hospital factors were examined. Length of stay in hospital served as a predictor of re-presentation in six studies; of these, five studies reported that a longer length of stay increased the risk of subsequent hospital readmissions [24, 25, 29, 50]. An American Society of Anesthesiologists (ASA) score > 3 was positively associated with risk of hospital readmission [30] in one of the four studies in which it was investigated. In another study, surgical delay of 24 hours or more was associated with readmission [28]. One study observed that older adults admitted into a geriatric unit managed by a multidisciplinary team had lower risk of hospital readmission and improved walking ability [21].

Quality assessment

Findings from the quality assessment of the studies are presented in Table 4. The global rating score for most studies (n = 17; 48 %) was in the ‘moderate’ category. However, the quality of 11 of the 35 studies (31 %) was classified as ‘strong’. All 11 strong studies examined patients with hip fractures. Another seven studies (7 %), which examined older adults with hip fractures, received a score of ‘weak’. The weaknesses most frequently identified were a failure to report drop outs or withdrawals, a lack of clear explanation about data collection processes, and inadequate descriptions of how potential confounders were controlled for.
Table 4
Quality assessment classifications from the Effective Public Health Practice Project Quality Assessment Tool
Lead author
Year
Selection bias
Study design
Confounder
Blinding
Data collection
Dropouts & withdrawals
Global rating
Basques
2015 [30]
Moderate
Moderate
Moderate
Moderate
Strong
Weak
Moderate
Bischoff-Ferrari
2010 [20]
Weak
Strong
Strong
Strong
Moderate
Strong
Strong
Boddaert
2014 [21]
Moderate
Moderate
Strong
Moderate
Strong
Strong
Strong
Fox
1998 [31]
Weak
Moderate
Weak
Moderate
Strong
Weak
Weak
French
2008 [25]
Moderate
Moderate
Weak
Moderate
Strong
Strong
Moderate
Giusti
2008 [32]
Strong
Moderate
Weak
Moderate
Strong
Strong
Moderate
Golinvaux
2014 [48]
Moderate
Moderate
Strong
Moderate
Strong
Strong
Strong
Gregersen
2011 [42]
Moderate
Moderate
Strong
Moderate
Strong
Strong
Strong
Hageman
2014 [43]
Moderate
Moderate
Weak
Moderate
Strong
Weak
Weak
Halm
2003 [27]
Strong
Moderate
Strong
Moderate
Strong
Strong
Strong
Halm
2003 [33]
Strong
Moderate
Strong
Moderate
Strong
Strong
Strong
Halm
2004 [34]
Strong
Moderate
Strong
Moderate
Strong
Strong
Strong
Härstedt
2015 [35]
Strong
Moderate
Weak
Moderate
Strong
Strong
Moderate
Heyes
2015 [29]
Moderate
Moderate
Weak
Moderate
Strong
Moderate
Moderate
Heidari
2012 [26]
Moderate
Moderate
Strong
Moderate
Strong
Weak
Moderate
Hsaio
2011 [23]
Moderate
Moderate
Strong
Moderate
Weak
Weak
Weak
Intrator
1998 [44]
Weak
Moderate
Strong
Moderate
Strong
Strong
Weak
Jou
2014 [24]
Moderate
Moderate
Strong
Moderate
Weak
Weak
Weak
Kates
2014 [28]
Moderate
Moderate
Weak
Moderate
Strong
Strong
Moderate
Kates
2015 [49]
Moderate
Moderate
Weak
Moderate
Strong
Strong
Moderate
Khan
2012 [36]
Moderate
Moderate
Weak
Moderate
Strong
Moderate
Moderate
Kiel
1994 [45]
Moderate
Moderate
Weak
Moderate
Strong
Strong
Moderate
Le-Wendling
2012 [37]
Moderate
Moderate
Strong
Moderate
Weak
Strong
Moderate
Ling
2013 [19]
Moderate
Moderate
Moderate
Moderate
Strong
Weak
Moderate
Merchant
2005 [38]
Moderate
Moderate
Moderate
Moderate
Strong
Strong
Strong
Ottenbacher
2003 [46]
Moderate
Moderate
Weak
Moderate
Strong
Moderate
Moderate
Pollock
2015 [50]
Moderate
Moderate
Weak
Moderate
Strong
Weak
Weak
Radcliff
2008 [51]
Moderate
Moderate
Strong
Moderate
Strong
Strong
Strong
Riggs
2010 [39]
Moderate
Moderate
Moderate
Moderate
Strong
Weak
Moderate
Teixeira
2009 [40]
Moderate
Moderate
Moderate
Moderate
Strong
Strong
Strong
Toson
2015 [53]
Moderate
Moderate
Moderate
Moderate
Strong
Moderate
Strong
Toy
2014 [41]
Moderate
Moderate
Weak
Moderate
Strong
Strong
Moderate
Tsai
2013 [47]
Moderate
Moderate
Strong
Moderate
Weak
Weak
Moderate
Vochteloo
2011 [22]
Moderate
Moderate
Strong
Moderate
Strong
Weak
Moderate
Zhang
2014 [52]
Moderate
Moderate
Weak
Moderate
Moderate
Weak
Weak

Best-evidence synthesis

Eleven studies met the inclusion criteria for high quality studies. In accordance with the global rating scale, these studies had no ‘weak’ ratings in any sub-domain (Table 4). Five of these studies (45 % of high quality studies) reported at least one statistically significant risk factor of hospital readmission that was identifiable at the index admission [21, 27, 40, 42, 53]. Among the patient factors associated with readmission in these five studies, age was positively associated with hospital readmission in one study [21]. One study each out of the 11 high quality studies identified male sex, lower post-operative Hb level, and higher CIRS score at index admission to have positive associations with hospital re-presentations [21, 40, 42]. Comorbidities that were significantly associated with hospital re-presentations in these studies included impaired sensorium, renal insufficiencies, asthma, chronic liver disease, dementia, cancer, ‘new impairments’ on discharge, adverse effects of glucocorticoids, and androgen therapy [21, 27, 40, 42, 51]. In summary, of the 11 high quality studies (31 % of all included studies), five provided evidence of statistically significant findings, and the correlates that were significant varied among studies.

Meta-analysis

The meta-analysis indicated age was associated with increased risk of hospital readmission both within a 30-day time-frame and beyond a 30-day time-frame (Fig. 2), with the 95 % CIs of the pooled effect estimate not inclusive of 1.00. The random-effects pooled OR was 1.27 (95 % CI, 1.14–1.43) for the effect of age on the risk of hospital readmission within 30 days (Fig. 2a). However, a large amount of heterogeneity (I2 = 98 %) in study effect size estimates was observed. The random-effects pooled OR was 1.23 (95 % CI, 1.01–1.50) for the effect of age on the risk of hospital readmission > 30 days (Fig. 2b). The heterogeneity was also large (I2 = 94 %) among studies reporting hospital readmission > 30 days. The sensitivity analysis indicated that the removal of the small study [19] with an outlying effect estimate had no difference on the pooled effect estimate (Fig. 2c) and had a negligible effect on overall heterogeneity (I2 = 97 %). It is noteworthy that the calculations that were required to determine pooled effect estimates from studies with disparate analysis and reporting approaches resulted in pooled ORs that cannot be interpreted as simple effects per increasing year of age. However, the findings of an increasing risk with age, the demonstrated significance at a 95 % CI, and the substantial variation in reported effect among studies were noteworthy findings from the meta-analysis.

Discussion

There are a number of useful inferences and research priorities that can be drawn from the findings reported in this review. A key finding was that age was the most frequently investigated risk factor for hospital readmission. The meta-analysis confirmed age as a predictor of hospital re-presentations both within 30 days and for re-presentations occurring after 30 days. Although age is not modifiable, interventions that target high-risk older adults before they leave hospital have been cost-effective in reducing undesirable outcomes, and it has been suggested that there may be some utility for these interventions to be offered to older people recovering from fragility fractures [54, 55]. An important consideration for future research investigating age as a predictor of hospital re-presentations may be to consider the linearity of the effect of age on risk of re-presentation to hospital. The risk of readmission may not increase uniformly with increasing age in years, but rather, there may be an accelerating increase in risk of readmission with advancing age among people recovering from fragility fractures. However, further research is required to confirm or refute this hypothesis in the context of older adults recovering from fragility fractures.
There was a high degree of variation (methodologies, reporting quality, and results) across studies reporting other potential risk factors. A salient finding from this review was that studies with a high quality rating reported the following factors, which were identified at the index admission, to be significant predictors of re-presentation to hospital: higher CIRS, ASA > 3, cardiovascular diseases, low post-operative Hb, kidney diseases, dementia, and cancer [21, 27, 40, 42, 51]. Other potential predictors identified from studies with a moderate quality rating included anemia, neurological disorders, delirium, renal failure, diabetes, longer length of stay, and being discharged to a residential nursing care facility [22, 25, 28, 36]. Like age, many of these risk factors are likely to be difficult to modify in the context of clinical care during a hospitalization. However, they may prove useful for guiding the delivery of appropriate (and potentially targeted) care models to offset this risk. Co-morbidities and length of stay, which were reported as potential risk indicators in the present review, are generally consistent with research among other clinical populations [13, 56, 57]. This is a useful finding, so far as it implies that interventions to reduce re-presentations that have been successful among other clinical populations are worthy of consideration for adaptation and evaluation, specifically among patients with fragility fractures.
It was interesting to note that no factor that was investigated in multiple studies was consistently associated with readmission in all studies in which it was investigated. This observation of inconsistency among studies for the same risk factor may seem innocuous, but in actuality highlights one of the key challenges in the field. The inconsistency may be attributable to genuine variation in risk factors between populations and dissimilar health services; however, it may be attributable to methodological and reporting inconsistencies among studies that may have contributed to seemingly incongruent findings. This review has highlighted the extent of these inconsistencies among studies in a systematic way for the first time and should act as a call to reduce unnecessary variation between health services and research methodologies in this field.
Perhaps of even greater importance than potential inconsistencies in findings was the gap in the literature revealed in this systematic review. Specifically, a novel finding was that no study was identified that had examined risk factors for re-presentation to ED without hospital admission. Older adults disproportionately consume ED resources and have been reported to account for 20 % of presentations to EDs [58, 59]. This absence of studies examining re-presentations to EDs without admission to hospital by patients recovering from fragility fractures represents an important gap in the literature worthy of further research to advance the field.
It was also notable that most of the 35 studies focused on people treated for a hip fracture, including the eleven studies with highest quality ratings [20, 21, 27, 33, 34, 38, 40, 42, 48, 51, 53]. Identifying the paucity of high quality studies that have examined risk factors for re-presentation to hospital following fragility fractures that affect other important body regions (e.g., spine, shoulder, pelvis (non-hip), ankle, wrist, and forearm) is another important finding from this review. Nonetheless, this review has provided a consolidated synthesis of risk factors for hospital re-presentations taking into account study quality and consistency (and inconsistencies) among studies.

Strengths and limitations

A major strength of this review was that it used broad search terms and multiple databases. A rigorous screening process was implemented, including two researchers to independently conduct each stage of screening, data extraction, and quality appraisal. The investigators also considered it beneficial to have used the same quality measurement tool that could be applied across a range of study designs. This reduced the potential for quality rating bias attributable to use of differing quality rating instruments for different study designs. Along with the aforementioned strengths were some notable limitations of this review. First, the review was restricted to peer-reviewed journal articles published in the English language. Second, the inclusion of a range of study designs, sample characteristics, and lengths of study enrolment periods contributed to heterogeneity that prohibited the valid pooling of data for meta-analyses for most potential predictors. This was compounded by other methodological and reporting differences across studies.

Conclusions

There are several important recommendations for future research following this investigation. First, further robust examinations of risk factors for re-presentation to hospital among patients who have sustained fragility fractures beyond those affected by hip fractures are warranted. Second, investigation of risk factors for ED re-presentation without admission are also worthy of investigation. Understanding risk factors for these re-presentations may inform service enhancement to reduce the need for these patients to present to a hospital ED. Third, investigations into how specific elements of geriatric clinical care models potentially related to risk of re-presentation can be optimized to reduce risk would be beneficial. While some differences in findings among studies may be attributable to study methodology, it is likely that other discrepancies were due to local clinical, patient, or environmental factors. A greater understanding of the reasons for variations in risk factors across geographical locations, services, and patient samples may inform the development of interventions or alternative models of care for improving patient care and reducing risk.
A further pragmatic consideration is that the use of emergency services and readmissions to hospitals other than where the primary admission took place ought to be considered wherever possible. Moreover, consistency in the categorization of variables (e.g., age), definition of the index event (e.g., date of discharge), and follow-up periods (e.g. 30, 60, and 90 days) would be beneficial for comparability across studies.

Acknowledgements

SMM is supported by a National Health and Medical Research Council (of Australia) Fellowship.

Funding

Not applicable.

Availability of data and materials

No additional data are available, though details on statistical analysis are available from the corresponding author on request.

Authors’ contributions

SAM, EG, KCH, and SMM conceptualized, designed and drafted the study protocol. SAM conducted initial searches. SAM, EG, and SMM screened and identified studies for inclusion. SAM, EG and SMM assessed the quality of the studies and contribute to data analysis. SAM and SMM were responsible for principle manuscript drafting. SAM, EG, KH, and SMM contributed to manuscript editing and appraisal. All authors read and approved the final manuscript. The authors have no conflicts of interest to declare.

Competing interests

The authors declare that they have no competing interests.
Not applicable.
Not applicable.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Literatur
1.
Zurück zum Zitat Aoyagi K. Osteoporosis and osteoporotic fractures in the elderly. Acta Med Nagasaki. 2004;49(1–2):7–11. Aoyagi K. Osteoporosis and osteoporotic fractures in the elderly. Acta Med Nagasaki. 2004;49(1–2):7–11.
2.
Zurück zum Zitat Burke-Doe A, Hudson A, Werth H, Riordan DG. Knowledge of osteoporosis risk factors and prevalence of risk factors for osteoporosis, falls and fracture in functionally independent older adults. J Geriatr Phys Ther. 2008;31(1):11–7.CrossRefPubMed Burke-Doe A, Hudson A, Werth H, Riordan DG. Knowledge of osteoporosis risk factors and prevalence of risk factors for osteoporosis, falls and fracture in functionally independent older adults. J Geriatr Phys Ther. 2008;31(1):11–7.CrossRefPubMed
4.
Zurück zum Zitat Gerdhem P. Osteoporosis and fragility fractures: vertebral fractures. Best Pract Res Clin Rheumatol. 2013;27(6):743–55.CrossRefPubMed Gerdhem P. Osteoporosis and fragility fractures: vertebral fractures. Best Pract Res Clin Rheumatol. 2013;27(6):743–55.CrossRefPubMed
5.
Zurück zum Zitat Roland M, Dusheiko M, Gravelle H, Parker S. Follow up of people aged 65 and over with a history of emergency admissions: analysis of routine admission data. BMJ. 2005;330(7486):289–92.CrossRefPubMedPubMedCentral Roland M, Dusheiko M, Gravelle H, Parker S. Follow up of people aged 65 and over with a history of emergency admissions: analysis of routine admission data. BMJ. 2005;330(7486):289–92.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat McPhail SM. Multimorbidity in chronic disease: impact on health care resources and costs. J Risk Manag Healthc Policy. 2016;9:143–56.CrossRef McPhail SM. Multimorbidity in chronic disease: impact on health care resources and costs. J Risk Manag Healthc Policy. 2016;9:143–56.CrossRef
7.
Zurück zum Zitat Buecking B, Eschbach D, Koutras C, Kratz T, Balzer-Geldsetzer M, Dodel R, Ruchholtz S. Re-admission to level 2 unit after hip-fracture surgery – risk factors, reasons and outcome. Injury. 2013;44(12):1919–25.CrossRefPubMed Buecking B, Eschbach D, Koutras C, Kratz T, Balzer-Geldsetzer M, Dodel R, Ruchholtz S. Re-admission to level 2 unit after hip-fracture surgery – risk factors, reasons and outcome. Injury. 2013;44(12):1919–25.CrossRefPubMed
9.
Zurück zum Zitat Moore G, Gerdtz M, Manias E, Hepworth G, Dent A. Socio-demographic and clinical characteristics of re-presentation to an Australian inner-city emergency department: implications for service delivery. BMC Public Health. 2007;7:1.CrossRef Moore G, Gerdtz M, Manias E, Hepworth G, Dent A. Socio-demographic and clinical characteristics of re-presentation to an Australian inner-city emergency department: implications for service delivery. BMC Public Health. 2007;7:1.CrossRef
10.
Zurück zum Zitat Minnee D, Wilkinson J. Return visits to the emergency department and related hospital admissions by people aged 65 and over. N Z Med J. 2011;124(1331):67–74.PubMed Minnee D, Wilkinson J. Return visits to the emergency department and related hospital admissions by people aged 65 and over. N Z Med J. 2011;124(1331):67–74.PubMed
11.
Zurück zum Zitat Khan SK, Kalra S, Khanna A, Thiruvengada MM, Parker MJ. Timing of surgery for hip fractures: a systematic review of 52 published studies involving 291,413 patients. Injury. 2009;40(7):692–7.CrossRefPubMed Khan SK, Kalra S, Khanna A, Thiruvengada MM, Parker MJ. Timing of surgery for hip fractures: a systematic review of 52 published studies involving 291,413 patients. Injury. 2009;40(7):692–7.CrossRefPubMed
12.
Zurück zum Zitat Nazrun AS, Tzar MN, Mokhtar SA, Mohamed IN. A systematic review of the outcomes of osteoporotic fracture patients after hospital discharge: morbidity, subsequent fractures, and mortality. Ther Clin Risk Manag. 2014;10:937–48.PubMedPubMedCentral Nazrun AS, Tzar MN, Mokhtar SA, Mohamed IN. A systematic review of the outcomes of osteoporotic fracture patients after hospital discharge: morbidity, subsequent fractures, and mortality. Ther Clin Risk Manag. 2014;10:937–48.PubMedPubMedCentral
13.
Zurück zum Zitat García-Pérez L, Linertová R, Lorenzo-Riera A, Vázquez-Díaz JR, Duque-González B, Sarría-Santamera A. Risk factors for hospital readmissions in elderly patients: a systematic review. QJM. 2011;104(8):639–51.CrossRefPubMed García-Pérez L, Linertová R, Lorenzo-Riera A, Vázquez-Díaz JR, Duque-González B, Sarría-Santamera A. Risk factors for hospital readmissions in elderly patients: a systematic review. QJM. 2011;104(8):639–51.CrossRefPubMed
14.
Zurück zum Zitat Mathew S, Heesch K, Gane E, McPhail S. Risk factors for hospital re-presentation among older adults following fragility fractures: protocol for a systematic review. Syst Rev. 2015;4:91.CrossRefPubMedPubMedCentral Mathew S, Heesch K, Gane E, McPhail S. Risk factors for hospital re-presentation among older adults following fragility fractures: protocol for a systematic review. Syst Rev. 2015;4:91.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Deeks JJ, Dinnes J, D’amico R, Sowden A, Sakarovitch C, Song F, Petticrew M, Altman D. Evaluating non-randomised intervention studies. Health Technol Assess. 2003;7(27):1–179.CrossRef Deeks JJ, Dinnes J, D’amico R, Sowden A, Sakarovitch C, Song F, Petticrew M, Altman D. Evaluating non-randomised intervention studies. Health Technol Assess. 2003;7(27):1–179.CrossRef
16.
Zurück zum Zitat Jackson N, Waters E. Criteria for the systematic review of health promotion and public health interventions. Health Promot Int. 2005;20(4):367–74.CrossRefPubMed Jackson N, Waters E. Criteria for the systematic review of health promotion and public health interventions. Health Promot Int. 2005;20(4):367–74.CrossRefPubMed
17.
Zurück zum Zitat Slavin RE. Best evidence synthesis: an intelligent alternative to meta-analysis. J Clin Epidemiol. 1995;48(1):9–18.CrossRefPubMed Slavin RE. Best evidence synthesis: an intelligent alternative to meta-analysis. J Clin Epidemiol. 1995;48(1):9–18.CrossRefPubMed
19.
Zurück zum Zitat Ling XW, Howe TS, Koh JSB, Wong MK, Ng ACM. Preoperative thyroid dysfunction predicts 30-day postoperative complications in elderly patients with hip fracture. Geriatr Orthop Surg Rehabil. 2013;4(2):43–9.CrossRefPubMedPubMedCentral Ling XW, Howe TS, Koh JSB, Wong MK, Ng ACM. Preoperative thyroid dysfunction predicts 30-day postoperative complications in elderly patients with hip fracture. Geriatr Orthop Surg Rehabil. 2013;4(2):43–9.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Bischoff-Ferrari HA, Dawson-Hughes B, Platz A, Orav EJ, Stahelin HB, Willett WC, Can U, Egli A, Mueller NJ, Looser S, et al. Effect of high-dosage cholecalciferol and extended physiotherapy on complications after hip fracture: a randomized controlled trial. Arch Intern Med. 2010;170(9):813–20.CrossRefPubMed Bischoff-Ferrari HA, Dawson-Hughes B, Platz A, Orav EJ, Stahelin HB, Willett WC, Can U, Egli A, Mueller NJ, Looser S, et al. Effect of high-dosage cholecalciferol and extended physiotherapy on complications after hip fracture: a randomized controlled trial. Arch Intern Med. 2010;170(9):813–20.CrossRefPubMed
21.
Zurück zum Zitat Boddaert J, Cohen-Bittan J, Khiami F, Le Manach Y, Raux M, Beinis JY, Verny M, Riou B. Postoperative admission to a dedicated geriatric unit decreases mortality in elderly patients with hip fracture. PLoS One. 2014;9(1):e83795.CrossRefPubMedPubMedCentral Boddaert J, Cohen-Bittan J, Khiami F, Le Manach Y, Raux M, Beinis JY, Verny M, Riou B. Postoperative admission to a dedicated geriatric unit decreases mortality in elderly patients with hip fracture. PLoS One. 2014;9(1):e83795.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Vochteloo AJ, van der Burg BL B, Mertens B, Niggebrugge AH, de Vries MR, Tuinebreijer WE, Bloem RM, Nelissen RG, Pilot P. Outcome in hip fracture patients related to anemia at admission and allogeneic blood transfusion: an analysis of 1262 surgically treated patients. BMC Musculoskelet Disord. 2011;12:262.CrossRefPubMedPubMedCentral Vochteloo AJ, van der Burg BL B, Mertens B, Niggebrugge AH, de Vries MR, Tuinebreijer WE, Bloem RM, Nelissen RG, Pilot P. Outcome in hip fracture patients related to anemia at admission and allogeneic blood transfusion: an analysis of 1262 surgically treated patients. BMC Musculoskelet Disord. 2011;12:262.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Hsiao F-Y, Huang W-F, Chen Y-M, Wen Y-W, Kao Y-H, Chen L-K, Tsai Y-W. Hip and subtrochanteric or diaphyseal femoral fractures in alendronate users: a 10-year, nationwide retrospective cohort study in Taiwanese women. Clin Ther. 2011;33(11):1659–67.CrossRefPubMed Hsiao F-Y, Huang W-F, Chen Y-M, Wen Y-W, Kao Y-H, Chen L-K, Tsai Y-W. Hip and subtrochanteric or diaphyseal femoral fractures in alendronate users: a 10-year, nationwide retrospective cohort study in Taiwanese women. Clin Ther. 2011;33(11):1659–67.CrossRefPubMed
24.
Zurück zum Zitat Jou HJ, Siao RY, Tsai YS, Chen YT, Li CY, Chen CC. Postdischarge rehospitalization and in-hospital mortality among Taiwanese women with hip fracture. Taiwan J Obstet Gynecol. 2014;53(1):43–7.CrossRefPubMed Jou HJ, Siao RY, Tsai YS, Chen YT, Li CY, Chen CC. Postdischarge rehospitalization and in-hospital mortality among Taiwanese women with hip fracture. Taiwan J Obstet Gynecol. 2014;53(1):43–7.CrossRefPubMed
25.
Zurück zum Zitat French DD, Bass E, Bradham DD, Campbell RR, Rubenstein LZ. Rehospitalization after hip fracture: predictors and prognosis from a national veterans study. J Am Geriatr Soc. 2008;56(4):705–10.CrossRefPubMed French DD, Bass E, Bradham DD, Campbell RR, Rubenstein LZ. Rehospitalization after hip fracture: predictors and prognosis from a national veterans study. J Am Geriatr Soc. 2008;56(4):705–10.CrossRefPubMed
26.
Zurück zum Zitat Heidari N, Jehan S, Alazzawi S, Bynoth S, Bottle A, Loeffler M. Mortality and morbidity following hip fractures related to hospital thromboprophylaxis policy. Hip Int. 2012;22(1):13–21.CrossRefPubMed Heidari N, Jehan S, Alazzawi S, Bynoth S, Bottle A, Loeffler M. Mortality and morbidity following hip fractures related to hospital thromboprophylaxis policy. Hip Int. 2012;22(1):13–21.CrossRefPubMed
27.
Zurück zum Zitat Halm EA, Magaziner J, Hannan EL, Wang JJ, Silberzweig SB, Boockvar K, Orosz GM, McLaughlin MA, Koval KJ, Siu AL. Frequency and impact of active clinical issues and new impairments on hospital discharge in patients with hip fracture. Arch Intern Med. 2003;163(1):108–13.CrossRefPubMed Halm EA, Magaziner J, Hannan EL, Wang JJ, Silberzweig SB, Boockvar K, Orosz GM, McLaughlin MA, Koval KJ, Siu AL. Frequency and impact of active clinical issues and new impairments on hospital discharge in patients with hip fracture. Arch Intern Med. 2003;163(1):108–13.CrossRefPubMed
28.
Zurück zum Zitat Kates SL, Behrend C, Mendelson DA, Cram P, Friedman SM. Hospital readmission after hip fracture. Arch Orthop Trauma Surg. 2014;135(3):329–37.CrossRefPubMed Kates SL, Behrend C, Mendelson DA, Cram P, Friedman SM. Hospital readmission after hip fracture. Arch Orthop Trauma Surg. 2014;135(3):329–37.CrossRefPubMed
29.
Zurück zum Zitat Heyes GJ, Tucker A, Marley D, Foster A. Predictors for readmission up to 1 year following hip fracture. Arch Trauma Res. 2015;4(2):e27123.PubMedPubMedCentral Heyes GJ, Tucker A, Marley D, Foster A. Predictors for readmission up to 1 year following hip fracture. Arch Trauma Res. 2015;4(2):e27123.PubMedPubMedCentral
30.
Zurück zum Zitat Basques BA, Bohl DD, Golinvaux NS, Leslie MP, Baumgaertner MR, Grauer JN. Postoperative length of stay and 30-day readmission after geriatric hip fracture: an analysis of 8434 patients. J Orthop Trauma. 2015;29(3):e115–20.CrossRefPubMed Basques BA, Bohl DD, Golinvaux NS, Leslie MP, Baumgaertner MR, Grauer JN. Postoperative length of stay and 30-day readmission after geriatric hip fracture: an analysis of 8434 patients. J Orthop Trauma. 2015;29(3):e115–20.CrossRefPubMed
31.
Zurück zum Zitat Fox KM, Hawkes WG, Hebel JR, Felsenthal G, Clark M, Zimmerman SI, Kenzora JE, Magaziner J. Mobility after hip fracture predicts health outcomes. J Am Geriatr Soc. 1998;46(2):169–73.CrossRefPubMed Fox KM, Hawkes WG, Hebel JR, Felsenthal G, Clark M, Zimmerman SI, Kenzora JE, Magaziner J. Mobility after hip fracture predicts health outcomes. J Am Geriatr Soc. 1998;46(2):169–73.CrossRefPubMed
32.
Zurück zum Zitat Giusti A, Barone A, Razzano M, Pizzonia M, Oliveri M, Pioli G. Predictors of hospital readmission in a cohort of 236 elderly discharged after surgical repair of hip fracture: one-year follow-up. Aging Clin Exp Res. 2008;20(3):253–9.CrossRefPubMed Giusti A, Barone A, Razzano M, Pizzonia M, Oliveri M, Pioli G. Predictors of hospital readmission in a cohort of 236 elderly discharged after surgical repair of hip fracture: one-year follow-up. Aging Clin Exp Res. 2008;20(3):253–9.CrossRefPubMed
33.
Zurück zum Zitat Halm EA, Wang JJ, Boockvar K, Penrod J, Silberzweig SB, Magaziner J, Koval KJ, Siu AL. Effects of blood transfusion on clinical and functional outcomes in patients with hip fracture. Transfusion. 2003;43(10):1358–65.CrossRefPubMed Halm EA, Wang JJ, Boockvar K, Penrod J, Silberzweig SB, Magaziner J, Koval KJ, Siu AL. Effects of blood transfusion on clinical and functional outcomes in patients with hip fracture. Transfusion. 2003;43(10):1358–65.CrossRefPubMed
34.
Zurück zum Zitat Halm EA, Wang JJ, Boockvar K, Penrod J, Silberzweig SB, Magaziner J, Koval KJ, Siu AL. The effect of perioperative anemia on clinical and functional outcomes in patients with hip fracture. J Orthop Trauma. 2004;18(6):369–74.CrossRefPubMedPubMedCentral Halm EA, Wang JJ, Boockvar K, Penrod J, Silberzweig SB, Magaziner J, Koval KJ, Siu AL. The effect of perioperative anemia on clinical and functional outcomes in patients with hip fracture. J Orthop Trauma. 2004;18(6):369–74.CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Härstedt M, Rogmark C, Sutton R, Melander O, Fedorowski A. Impact of comorbidity on 6-month hospital readmission and mortality after hip fracture surgery. Injury. 2015;46(4):713–8.CrossRefPubMed Härstedt M, Rogmark C, Sutton R, Melander O, Fedorowski A. Impact of comorbidity on 6-month hospital readmission and mortality after hip fracture surgery. Injury. 2015;46(4):713–8.CrossRefPubMed
36.
Zurück zum Zitat Khan MA, Hossain FS, Dashti Z, Muthukumar N. Causes and predictors of early re-admission after surgery for a fracture of the hip. J Bone Joint Surg. 2012;94(5):690–7.CrossRef Khan MA, Hossain FS, Dashti Z, Muthukumar N. Causes and predictors of early re-admission after surgery for a fracture of the hip. J Bone Joint Surg. 2012;94(5):690–7.CrossRef
37.
Zurück zum Zitat Le-Wendling L, Bihorac A, Baslanti TO, Lucas S, Sadasivan K, Wendling A, Heyman HJ, Boezaart A. Regional anesthesia as compared with general anesthesia for surgery in geriatric patients with hip fracture: does it decrease morbidity, mortality, and health care costs? Results of a single-centered study. Pain Med. 2012;13(7):948–56.CrossRefPubMedPubMedCentral Le-Wendling L, Bihorac A, Baslanti TO, Lucas S, Sadasivan K, Wendling A, Heyman HJ, Boezaart A. Regional anesthesia as compared with general anesthesia for surgery in geriatric patients with hip fracture: does it decrease morbidity, mortality, and health care costs? Results of a single-centered study. Pain Med. 2012;13(7):948–56.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Merchant RA, Lui KL, Ismail NH, Wong HP, Sitoh YY. The relationship between postoperative complications and outcomes after hip fracture surgery. Ann Acad Med Singapore. 2005;34(2):163–8.PubMed Merchant RA, Lui KL, Ismail NH, Wong HP, Sitoh YY. The relationship between postoperative complications and outcomes after hip fracture surgery. Ann Acad Med Singapore. 2005;34(2):163–8.PubMed
39.
Zurück zum Zitat Riggs RV, Roberts PS, Aronow H, Younan T. Joint replacement and hip fracture readmission rates: impact of discharge destination. PM R. 2010;2(9):806–10.CrossRefPubMed Riggs RV, Roberts PS, Aronow H, Younan T. Joint replacement and hip fracture readmission rates: impact of discharge destination. PM R. 2010;2(9):806–10.CrossRefPubMed
40.
Zurück zum Zitat Teixeira A, Trinquart L, Raphael M, Bastianic T, Chatellier G, Holstein J. Outcomes in older patients after surgical treatment for hip fracture: a new approach to characterise the link between readmissions and the surgical stay. Age Ageing. 2009;38(5):584–9.CrossRefPubMed Teixeira A, Trinquart L, Raphael M, Bastianic T, Chatellier G, Holstein J. Outcomes in older patients after surgical treatment for hip fracture: a new approach to characterise the link between readmissions and the surgical stay. Age Ageing. 2009;38(5):584–9.CrossRefPubMed
41.
Zurück zum Zitat Toy JO, Basques BA, Grauer JN. Morbidity, mortality, and readmission after vertebral augmentation: analysis of 850 patients from the American College of Surgeons National Surgical Quality Improvement Program database. Spine. 2014;39(23):1943–9.CrossRefPubMed Toy JO, Basques BA, Grauer JN. Morbidity, mortality, and readmission after vertebral augmentation: analysis of 850 patients from the American College of Surgeons National Surgical Quality Improvement Program database. Spine. 2014;39(23):1943–9.CrossRefPubMed
42.
Zurück zum Zitat Gregersen M, Zintchouk D, Borris LC, Damsgaard EM. A geriatric multidisciplinary and tailor-made hospital-at-home method in nursing home residents with hip fracture. Geriatr Orthop Surg Rehabil. 2011;2(4):148–54.CrossRefPubMedPubMedCentral Gregersen M, Zintchouk D, Borris LC, Damsgaard EM. A geriatric multidisciplinary and tailor-made hospital-at-home method in nursing home residents with hip fracture. Geriatr Orthop Surg Rehabil. 2011;2(4):148–54.CrossRefPubMedPubMedCentral
43.
Zurück zum Zitat Hageman MGJS, Bossen JKJ, Smith RM, Ring D. Predictors of readmission in orthopaedic trauma surgery. J Orthop Trauma. 2014;28(10):e247–9.CrossRefPubMed Hageman MGJS, Bossen JKJ, Smith RM, Ring D. Predictors of readmission in orthopaedic trauma surgery. J Orthop Trauma. 2014;28(10):e247–9.CrossRefPubMed
44.
Zurück zum Zitat Intrator O, Berg K. Benefits of home health care after inpatient rehabilitation for hip fracture: health service use by Medicare beneficiaries, 1987–1992. Arch Phys Med Rehabil. 1998;79(10):1195–9.CrossRefPubMed Intrator O, Berg K. Benefits of home health care after inpatient rehabilitation for hip fracture: health service use by Medicare beneficiaries, 1987–1992. Arch Phys Med Rehabil. 1998;79(10):1195–9.CrossRefPubMed
45.
Zurück zum Zitat Kiel DP, Eichorn A, Intrator O, Silliman RA, Mor V. The outcomes of patients newly admitted to nursing homes after hip fracture. Am J Public Health. 1994;84(8):1281–6.CrossRefPubMedPubMedCentral Kiel DP, Eichorn A, Intrator O, Silliman RA, Mor V. The outcomes of patients newly admitted to nursing homes after hip fracture. Am J Public Health. 1994;84(8):1281–6.CrossRefPubMedPubMedCentral
46.
Zurück zum Zitat Ottenbacher KJ, Smith PM, Illig SB, Peek MK, Fiedler RC, Granger CV. Hospital readmission of persons with hip fracture following medical rehabilitation. Arch Gerontol Geriatr. 2003;36(1):15–22.CrossRefPubMed Ottenbacher KJ, Smith PM, Illig SB, Peek MK, Fiedler RC, Granger CV. Hospital readmission of persons with hip fracture following medical rehabilitation. Arch Gerontol Geriatr. 2003;36(1):15–22.CrossRefPubMed
47.
Zurück zum Zitat Tsai YW, Hsiao FY, Wen YW, Kao YH, Chang LC, Huang WF, Peng LN, Liu CL, Chen LK. Clinical outcomes of vertebroplasty or kyphoplasty for patients with vertebral compression fractures: a nationwide cohort study. J Am Med Dir Assoc. 2013;14(1):41–7.CrossRefPubMed Tsai YW, Hsiao FY, Wen YW, Kao YH, Chang LC, Huang WF, Peng LN, Liu CL, Chen LK. Clinical outcomes of vertebroplasty or kyphoplasty for patients with vertebral compression fractures: a nationwide cohort study. J Am Med Dir Assoc. 2013;14(1):41–7.CrossRefPubMed
48.
Zurück zum Zitat Golinvaux NS, Bohl DD, Basques BA, Baumgaertner MR, Grauer JN. Diabetes confers little to no increased risk of postoperative complications after hip fracture surgery in geriatric patients. Clin Orthop Relat Res. 2014;473(3):1043–51.CrossRefPubMedPubMedCentral Golinvaux NS, Bohl DD, Basques BA, Baumgaertner MR, Grauer JN. Diabetes confers little to no increased risk of postoperative complications after hip fracture surgery in geriatric patients. Clin Orthop Relat Res. 2014;473(3):1043–51.CrossRefPubMedPubMedCentral
49.
Zurück zum Zitat Kates SL, Shields E, Behrend C, Noyes KK. Financial implications of hospital readmission after hip fracture. Geriatr Orthop Surg Rehabil. 2015;6(3):140–6.CrossRefPubMedPubMedCentral Kates SL, Shields E, Behrend C, Noyes KK. Financial implications of hospital readmission after hip fracture. Geriatr Orthop Surg Rehabil. 2015;6(3):140–6.CrossRefPubMedPubMedCentral
50.
Zurück zum Zitat Pollock FH, Bethea A, Samanta D, Modak A, Maurer JP, Chumbe JT. Readmission within 30 days of discharge after hip fracture care. Orthopedics. 2015;38(1):e7–13.CrossRefPubMedPubMedCentral Pollock FH, Bethea A, Samanta D, Modak A, Maurer JP, Chumbe JT. Readmission within 30 days of discharge after hip fracture care. Orthopedics. 2015;38(1):e7–13.CrossRefPubMedPubMedCentral
51.
Zurück zum Zitat Radcliff TA, Henderson WG, Stoner TJ, Khuri SF, Dohm M, Hutt E. Patient risk factors, operative care, and outcomes among older community-dwelling male veterans with hip fracture. J Bone Joint Surg Am. 2008;90A(1):34–42.CrossRef Radcliff TA, Henderson WG, Stoner TJ, Khuri SF, Dohm M, Hutt E. Patient risk factors, operative care, and outcomes among older community-dwelling male veterans with hip fracture. J Bone Joint Surg Am. 2008;90A(1):34–42.CrossRef
52.
Zurück zum Zitat Zhang AL, Schairer WW, Feeley BT. Hospital readmissions after surgical treatment of proximal humerus fractures: is arthroplasty safer than open reduction internal fixation? Clin Orthop Relat Res. 2014;472(8):2317–24.CrossRefPubMedPubMedCentral Zhang AL, Schairer WW, Feeley BT. Hospital readmissions after surgical treatment of proximal humerus fractures: is arthroplasty safer than open reduction internal fixation? Clin Orthop Relat Res. 2014;472(8):2317–24.CrossRefPubMedPubMedCentral
53.
Zurück zum Zitat Toson B, Harvey LA, Close JC. The ICD-10 Charlson Comorbidity Index predicted mortality but not resource utilization following hip fracture. J Clin Epidemiol. 2015;68(1):44–51.CrossRefPubMed Toson B, Harvey LA, Close JC. The ICD-10 Charlson Comorbidity Index predicted mortality but not resource utilization following hip fracture. J Clin Epidemiol. 2015;68(1):44–51.CrossRefPubMed
54.
Zurück zum Zitat Courtney M, Edwards H, Chang A, Parker A, Finlayson K, Hamilton K. Fewer emergency readmissions and better quality of life for older adults at risk of hospital readmission: a randomized controlled trial to determine the effectiveness of a 24‐week exercise and telephone follow‐up program. J Am Geriatr Soc. 2009;57(3):395–402.CrossRefPubMed Courtney M, Edwards H, Chang A, Parker A, Finlayson K, Hamilton K. Fewer emergency readmissions and better quality of life for older adults at risk of hospital readmission: a randomized controlled trial to determine the effectiveness of a 24‐week exercise and telephone follow‐up program. J Am Geriatr Soc. 2009;57(3):395–402.CrossRefPubMed
55.
Zurück zum Zitat Graves N, Courtney M, Edwards H, Chang A, Parker A, Finlayson K. Cost-effectiveness of an intervention to reduce emergency re-admissions to hospital among older patients. PLoS One. 2009;4(10):e7455.CrossRefPubMedPubMedCentral Graves N, Courtney M, Edwards H, Chang A, Parker A, Finlayson K. Cost-effectiveness of an intervention to reduce emergency re-admissions to hospital among older patients. PLoS One. 2009;4(10):e7455.CrossRefPubMedPubMedCentral
56.
Zurück zum Zitat Dailey EA, Cizik A, Kasten J, Chapman JR, Lee MJ. Risk factors for readmission of orthopaedic surgical patients. J Bone Joint Surg Am. 2013;95(11):1012–9.CrossRefPubMed Dailey EA, Cizik A, Kasten J, Chapman JR, Lee MJ. Risk factors for readmission of orthopaedic surgical patients. J Bone Joint Surg Am. 2013;95(11):1012–9.CrossRefPubMed
57.
Zurück zum Zitat Garcia-Aymerich J, Farrero E, Felez M, Izquierdo J, Marrades R, Anto J. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax. 2003;58(2):100–5.CrossRefPubMedPubMedCentral Garcia-Aymerich J, Farrero E, Felez M, Izquierdo J, Marrades R, Anto J. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax. 2003;58(2):100–5.CrossRefPubMedPubMedCentral
58.
Zurück zum Zitat Aminzadeh F, Dalziel WB. Older adults in the emergency department: a systematic review of patterns of use, adverse outcomes, and effectiveness of interventions. Ann Emerg Med. 2002;39(3):238–47.CrossRefPubMed Aminzadeh F, Dalziel WB. Older adults in the emergency department: a systematic review of patterns of use, adverse outcomes, and effectiveness of interventions. Ann Emerg Med. 2002;39(3):238–47.CrossRefPubMed
59.
Zurück zum Zitat Koehler BE, Richter KM, Youngblood L, Cohen BA, Prengler ID, Cheng D, Masica AL. Reduction of 30‐day postdischarge hospital readmission or emergency department (ED) visit rates in high‐risk elderly medical patients through delivery of a targeted care bundle. J Hosp Med. 2009;4(4):211–8.CrossRefPubMed Koehler BE, Richter KM, Youngblood L, Cohen BA, Prengler ID, Cheng D, Masica AL. Reduction of 30‐day postdischarge hospital readmission or emergency department (ED) visit rates in high‐risk elderly medical patients through delivery of a targeted care bundle. J Hosp Med. 2009;4(4):211–8.CrossRefPubMed
Metadaten
Titel
Risk factors for hospital re-presentation among older adults following fragility fractures: a systematic review and meta-analysis
verfasst von
Saira A. Mathew
Elise Gane
Kristiann C. Heesch
Steven M. McPhail
Publikationsdatum
01.12.2016
Verlag
BioMed Central
Erschienen in
BMC Medicine / Ausgabe 1/2016
Elektronische ISSN: 1741-7015
DOI
https://doi.org/10.1186/s12916-016-0671-x

Weitere Artikel der Ausgabe 1/2016

BMC Medicine 1/2016 Zur Ausgabe

Leitlinien kompakt für die Allgemeinmedizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Facharzt-Training Allgemeinmedizin

Die ideale Vorbereitung zur anstehenden Prüfung mit den ersten 24 von 100 klinischen Fallbeispielen verschiedener Themenfelder

Mehr erfahren

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Allgemeinmedizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.